RoshReview Acquired by Blueprint
Founded in 2011, Rosh Review is the industry-leading provider of online high-stakes exam prep and continuing education for medical students, nurse practitioners, and physician assistants. More than 228,000 learners and 740 institutions trust Rosh Review to meet their medical education needs. The Company is led by its founder and a talented roster of employees.
The team at Navagant advised Rosh Review on its sale to Blueprint, a leading test prep and tutoring provider for medical and law school candidates. This is the fourth add-on acquisition Blueprint had done since becoming a portfolio company of New Harbor Capital in 2018 (a transaction also advised by the team at Navagant).
Adam Rosh, CEO, Rosh Review
“Acquisitions tend to be highly stressful. In our case, having the Navagant team by our side made the journey quite enjoyable. There was no stress. The Navagant team had command. And what made all the difference was the people on the team. Each individual played a key role and together they exceeded our wildest expectations. I am forever grateful.”
Mike Sanders, COO of Rosh Review
“Our leadership team includes practicing clinicians who have a privileged understanding of the human condition which guides all decision. We had an obligation to our learners and team to find a partner to continue to build out our vision for medical education—and shared the same values. We wanted someone to represent us that shared our values, understood the EdTech industry, provided senior level attention, and worked with integrity. The Navagant team went beyond expectations in all categories. If you simply want to close a transaction, choose any firm. If you want to position your company to realize its fullest potential, work with the Navagant team.”
Jacob Voorhees, Managing Director, Navagant
“When we first were meeting with Adam & Mike, the first question asked was “why do we do what we do?” Our response was to improve patient care, which was right on the money. Rosh Review truly does make a difference in improved medical outcomes, especially in high-stress emergency room environments. The combination with Blueprint will only further that mission.”
Benefits & Long-Term Value Creation
As a patient, you probably don’t understand how Rosh Review may affect your life. If you have had an experience with physicians, physician assistants and nurses in emergency, family, internal, ob/gyn, pediatric or psychiatric medicine, they probably used Rosh Review as an education resource. Improved patient outcomes benefit everyone in society by lowering healthcare costs, prolonging life expectancy, and promoting mental wellbeing.
Acquiring Rosh Review grants Blueprint access to proven teaching methodologies, course materials, online learning platforms, and data-driven analytics across the medical spectrum. By incorporating these assets into their existing infrastructure, Blueprint can enhance its own offerings and provide Rosh Review with a well-capitalized partner to continue to expand into different areas of patient care.
Navagant LLC is a middle-market investment bank focused exclusively on the Education & Training industry. We serve entrepreneurs, family businesses, large corporations, and financial sponsors seeking to optimize their transaction outcomes. Our sell-side advisory services include mergers and acquisitions, majority and minority recapitalizations, management buyouts, and corporate carve-outs. With a conscious-capital mission and a team of experienced professionals, Navagant delivers tailored solutions to help organizations unlock value and achieve life-changing outcomes. For more information, please visit http://www.navagant.com.